Search bioRxivSearch

Biology subjects

Baxter, P.

Publications and source records attributed to Baxter, P..

2 recordsLinked to original sources

AVDM: Angular Velocity Decoding Model Accounting for Visually Guided Flight Behaviours of the Bee

We present a new angular velocity estimation model for explaining the honeybees flight behaviours of tunnel centring and terrain following, capable of reproducing observations of the large independence to the spatial frequency and contrast of the gratings in visually guide flights of honeybees. The model combines both temporal and texture information to decode the angular velocity well. The angular velocity estimation of the model is little affected by the spatial frequency and contrast in synthetic grating experiments. The model is also tested behaviourally in Unity with the tunnel centring and terrain following paradigms. Together with the proposed angular velocity based control algorithms, the virtual bee navigates well in a patterned tunnel and can keep a certain distance from undulating ground with gratings in a series of controlled trials. The results coincide with both neuron spike recordings and behavioural path recordings of honeybees, demonstrating that the model can explain how visual motion is detected in the bee brain.\n\nAuthor summaryBoth behavioural and electro-physiological experiments indicate that honeybees can estimate the angular velocity of image motion in their retinas to control their flights, while the neural mechanism behind has not been fully understood. In this paper, we present a new model based on previous experiments and models aiming to reproduce similar behaviours as real honeybees in tunnel centring and terrain following simulations. The model shows a large spatial frequency independence which outperforms the previous model, and our model generally reproduces the wanted behaviours in simulations.

animal behavior and cognition

Genomic landscape of 261 childhood cancer patient-derived xenograft models

Accelerating cures for children with cancer remains an immediate challenge due to extensive oncogenic heterogeneity between and within histologies, distinct molecular mechanisms evolving between diagnosis and relapsed disease, and limited therapeutic options. To systematically prioritize and rationally test novel agents in preclinical murine models, researchers within the Pediatric Preclinical Testing Consortium are continuously developing patient-derived xenografts (PDXs) from high-risk childhood cancers, many refractory to current standard-of-care treatments. Here, we genomically characterize 261 PDX models from 29 unique pediatric cancer malignancies and demonstrate faithful recapitulation of histologies, subtypes, and refine our understanding of relapsed disease. Expression and mutational signatures are used to classify tumors for TP53 and NF1 inactivation, as well as impaired DNA repair. We anticipate that these data will serve as a resource for pediatric oncology drug development and guide rational clinical trial design for children with cancer.\n\nHighlightsO_LIMultiplatform genomic analysis defines landscape of 261 pediatric cancer patient derived xenograft (PDX) models\nC_LIO_LIPediatric patient derived xenografts faithfully recapitulate relapsed disease\nC_LIO_LIInferred TP53 pathway inactivation correlates with pediatric cancer copy number burden\nC_LIO_LISomatic mutational signatures predict impaired DNA repair across multiple histologies\nC_LI

genomics